Francesca Alberton

1PUBLICATIONS
2CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 23, 2022
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment.

Francesca Alberton, Silvia Nozza, Angelo Roberto Raccagni

Pageof 1

Frequent Collaborators

1 joint publications

Angelo Roberto Raccagni

1 joint publications

Nicola Gianotti